Bharat Parenterals gets DCGI nod for Favipiravir oral suspension
Drug firm Bharat Parenterals on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir oral suspension, to be used for treatment of Covid-19 patients. The company has received licence…